Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Consensus Recommendation of “Buy” from Brokerages
Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) has earned a consensus rating of “Buy” from the nine brokerages that are covering the company, Marketbeat.com reports. Seven investment analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average 12-month price target among analysts […]
Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) has earned a consensus rating of “Buy” from the nine brokerages that are covering the company, Marketbeat.com reports. Seven investment analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average 12-month price target among analysts […]
